Global Low-MOQ Price War: Onoxa 12 Units, Selfnamed 0 MOQ, K-Beauty Factories Forced to 500 Units

The MOQ floor keeps dropping

The 2026 private-label landscape is defined by how low minimum order quantities have gone. Onoxa — GMP-certified and shipping within the U.S. — lets a brand launch with just 12 units per SKU across 50+ ready-to-brand products, at a 5–7 day average turnaround. Selfnamed in the EU pushes the model toward 0-MOQ. Meanwhile mainstream K-Beauty and Chinese factories still commonly quote 500–1,000 units as a realistic first order.

What the low number actually buys you

An MOQ of 12 is possible precisely because the formula already exists: buyers choose from a stable, tested, 'ready-to-brand' library and apply their own label. There is no traditional R&D stage, which removes most of the cost and time of formulation, sampling and batch development. For a founder testing whether a vitamin-C serum or cleanser will sell before committing to inventory, that structure is commercially sensible.

The trade-off you must plan for

The same standardisation that enables a 12-unit MOQ limits how much development can happen at that quantity. Onoxa itself describes its catalogue as 'ready-to-brand' with no development required. If you want to change active concentrations, rebuild the preservative system, or build a unique bottle and carton, that is a different conversation from a 12-unit white-label launch.

A balanced path

Metro Private Label positions itself for brands that want a manageable first production (roughly 500–1,000 units) while retaining formula customization, packaging coordination and a realistic scale-up path. The pragmatic play: validate with a small first run, then keep formula, packaging standard and quality controls consistent as you move into larger repeat orders.